SLC5A2 and nervous system disorder: Based on these reported benefits of the SGLT2 inhibitors, researchers are tempted to further examine the utility of these agents in the management of other diseases that are characterized by abnormal elevated levels of inflammation and oxidative stress, and more specifically, in neurological disorders.